Skip to main content

Advertisement

ADVERTISEMENT

Volume 24 - Issue 8 - August 2016

Column

Clinical Editor's Corner
07/26/2016

Compiled by Morton Kern with contributions from Steve Bailey, San Antonio, Texas; Peter Berger, New Hyde Park, New York; Jim Blankenship, Danville, Pennsylvania; Ted Feldman, Evanston, Illinois; David Kandzari, Atlanta, Georgia; Aaron Kaplan, Dartmouth, New Hampshire; Navin K. Kapur, Boston, Massachusetts; Ajay J. Kirtane, New York City, New York; Lloyd Klein, Chicago, Illinois; Jeffrey Moses, New York City, New York; Gurpreet Sandhu, Rochester, Minnesota; Gregg Stone, New York City, New York; George Vetrovec, Richmond, Virginia; Bonnie Weiner, Worchester, Massachusetts; Chris White, New Orleans, Louisiana [See contributor list at end].

*The Impella Left Ventricular Assist Device (Abiomed, Inc).

Compiled by Morton Kern with contribu...
In this “Conversation in Cardiology”, Dr. Ted Feldman from Evanston Hospital, Evanston, Illinois, asks, “Is the availability of Impella a requirement for every STEMI [ST-elevation myocardial infarction] program (even in lower volume programs...
In this “Conversation in Cardiology”, Dr. Ted Feldman from Evanston Hospital, Evanston, Illinois, asks, “Is the availability of Impella a requirement for every STEMI [ST-elevation myocardial infarction] program (even in lower volume programs...
In this “Conversation in...
07/26/2016
Cath Lab Digest

Advertisement

Advertisement

Advertisement